1. From the Division of Molecular Therapy, UCL Institute of Ophthalmology, London, United Kingdom; and
2. From the Division of Molecular Therapy, UCL Institute of Ophthalmology, London, United Kingdom; and the 2Department of Ophthalmology, Ruijin Hospital, Shanghai Jiao Tong University, China.